Insilico and ARK enter a research collaboration on health-span and longevity
Ageing Research at King's partners with Insilico to work on healthy ageing and longevity.
ARK pioneers in research on ageing while Insilico is an AI company dedicated to human productive longevity.
Aim to employ AI-based methods, to explore mechanisms of ageing and improving health-span.
An opportunity to deliver academic excellence in AI methods for ageing and longevity research.
Has significant potential to impact healthy ageing, age-related diseases and targeted therapeutics.